Amgen Inc. buy UBS Group AG
Start price
13.04.26
/
50%
€296.65
Target price
13.04.27
€342.24
Performance (%)
25.34%
Price
14:37
€369.30
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG currently has a performance of 25.34%. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 13.04.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 2.368% | 2.368% |
| iShares Core DAX® | -0,87 % | 5,32 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % |
| iShares S&P 500 | -0,65 % | 2,07 % |
Comments by UBS_Group_AG for this prediction
In the thread Amgen Inc. diskutieren
Amgen (AMGN) had its price target raised by UBS Group AG from $390.00 to $400.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat